Covalon Technologies Ltd. | Cash Flow

Fiscal year is October-September. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
993.20
2,401.80
942.00
3,095.10
1,811.70
1,617.60
Depreciation, Depletion & Amortization
315.50
296.20
241.60
233.50
269.20
356.40
Other Funds
40.00
79.50
-
-
-
1,264
Funds from Operations
660.70
2,944.30
337.80
2,318.90
2,709.80
3,238
Changes in Working Capital
825.20
158.20
1,930.30
1,293.10
2,694.70
3,893.50
Net Operating Cash Flow
1,485.90
3,102.50
2,268.10
1,025.80
15.10
655.50
Capital Expenditures
187.70
117.90
239.70
251.70
359.70
Sale of Fixed Assets & Businesses
-
-
92.70
34.30
-
Purchase/Sale of Investments
-
-
111.10
546.90
0.20
Net Investing Cash Flow
187.70
117.90
25.90
339.40
349.90
Issuance/Reduction of Debt, Net
731.20
41.00
-
-
-
Net Financing Cash Flow
1,172.90
90.50
-
893.50
3,190.50
Net Change in Cash
509.60
2,941.70
2,270.30
149.80
2,701.50
Free Cash Flow
1,570.40
3,090.40
2,440.30
1,127.60
284.90
Other Sources
-
-
10.00
10.00
10.00
Change in Capital Stock
481.70
30.00
-
893.50
3,190.50
Exchange Rate Effect
8.80
47.60
23.70
57.30
154.20

About Covalon Technologies

View Profile
Address
1660 Tech Avenue
Mississauga Ontario L4W 5S7
Canada
Employees -
Website http://www.covalon.com
Updated 07/08/2019
Covalon Technologies Ltd. engages in the research, development, manufacture, and marketing of patent-protected medical products. Its technologies focus on the wound care, infection management, and surgical procedures. It sells its products under the brand name Covalon.